Adjuvant Therapies in Breast Cancer and Quality of Life: A Critical Review of the TWiST Concept

Brunner, K. W.

doi:10.1007/978-3-642-83337-3_35

K. W. Brunner¹²

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 115))

62 Accesses
5 Citations

Abstract

The conventional end points of any curative cancer treatment are disease- and recurrence-free survival and overall long-term survival. It is customary to assume that any increase in the number of cured patients at 5 or 10 years justifies and compensates for all early and late side effects of treatment, not only for the cured but also for the unsuccessfully treated patients. Quality of life assessments rarely influence the evaluation of truly curative therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Chapter: USD 29.95; Price excludes VAT (USA)

eBook: USD 84.99; Price excludes VAT (USA)

Softcover Book: USD 109.99; Price excludes VAT (USA)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

References

Brunner KW (1987) Evaluation criteria in comparative clinical trials in advanced breast cancer: a proposal for improvement. In: Cavalli F (ed) Endocrine therapy of breast cancer II. Springer, Berlin Heidelberg New York Tokyo, p 45
Google Scholar
Coates AS for the Australian-New Zealand Breast Cancer Trials Group (1987) Improving the quality of life during chemotherapy for advanced breast cancer. N Engl J Med 317: 1490–1495
Article Google Scholar
Coates AS, Fischer Dillenbeck C, McNeil DR, et al. (1983) On the receiving end. II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy. Eur J Cancer Clin Oncol 19: 1633–1637
Article PubMed CAS Google Scholar
Gelber RD, Goldhirsch A (1986) A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol 4: 1722–1779
Google Scholar
Spitzer WO, Dobson AJ, Hall J, et al. (1981) Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis 34: 585–597
Article PubMed CAS Google Scholar

Download references

Author information

Authors and Affiliations

Institut für Medizinische Onkologie, Inselspital, Universität Bern, 3010, Bern, Switzerland
K. W. Brunner

Authors

K. W. Brunner
View author publications
You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

Medizinische Klinik C, Kantonsspital, 9007, St. Gallen, Switzerland
Hans-Jörg Senn
Servizio Oncologico Cantonale, Ospedale Civico, 6900, Lugano, Switzerland
Aron Goldhirsch
Division of Biostatistics and Epidemiology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA, 02115, USA
Richard D. Gelber
Abteilung für Hämatologie und Onkologie Medizinische Klinik C, Kantonsspital, 9007, St. Gallen, Switzerland
Bruno Osterwalder

Rights and permissions

Reprints and permissions

Copyright information

About this paper

Cite this paper

Brunner, K.W. (1989). Adjuvant Therapies in Breast Cancer and Quality of Life: A Critical Review of the TWiST Concept. In: Senn, HJ., Goldhirsch, A., Gelber, R.D., Osterwalder, B. (eds) Adjuvant Therapy of Primary Breast Cancer. Recent Results in Cancer Research, vol 115. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83337-3_35

Download citation

DOI: https://doi.org/10.1007/978-3-642-83337-3_35
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83339-7
Online ISBN: 978-3-642-83337-3
eBook Packages: Springer Book Archive

Publish with us

Policies and ethics